Sanofi's pick checks boxes in emerging markets, established products

Investors had a muted response to the appointment of Olivier Brandicourt as the new CEO at Sanofi (Euronext:SAN; NYSE:SNY), as the pharma's shares shed EUR 0.45 to EUR 87.39 on Euronext and were unchanged at $50.10 on NYSE on Friday, the

Read the full 415 word article

How to gain access

Continue reading with a
two-week free trial.